Table 1. Patient characteristics Patient... | American Society of Hematology

Table 1.

Patient characteristics

Patient and diagnosis		ABO Do→R^†	Donor	First donor RBC	Full donor myeloid	Full donor T	Full donor B	Acute GVHD	Response and status (d after transplantation)
01	CLL	A→O	Sib	151^1-213	NT	NT	NT	No	CR	A (518)
02	MM	A→O	MUD	44	26^*	26^*	26^*	No	Prog	D (427)
03	LGNHL	A→O	Sib	64	88^*	459	88^*	No	CR	A (725)
04	MM	A→O	MUD	67	88^*	238	88^*	No	PR	A (725)
05	HGNHL	A→O	MUD	49^1-213	45^*	286^1-213	45^*	No	CR	A (416)
06	MM	B→O	Sib	39	32^*	335	32^*	No	Prog	A (438)
07	HD	B→O	Sib	71	43^*	43^*	43^*	No	CR	A (1496)
08	MM	B→O	MUD	53	87^*	87^*	87^*	Gd 2	PR	A (731)
09	CML	A→B	Sib	88	195^*	728	195^*	No	CR	A (910)
10	MM	A→B	MUD	60	25^*	469^1-213	25^*	Gd 2	Prog	A (567)
11	HD	B→A	Sib	92	32^*	32^*	32^*	No	CRu	A (532)
12	HD	B→A	MUD	91^1-213	32^*	32^*	32^*	No	CRu	A (98)
13	LGNHL	AB→A	MUD	39	45^*	45^*	45^*	Gd 2	CR	A (433)
14	MM	AB→A	Sib	133	NT	NT	NT	No	PR	A (525)
15	LGNHL	AB→A	MUD	207^1-213	NT	NT	NT	No	PR	A (238)

Patient and diagnosis		ABO Do→R^†	Donor	First donor RBC	Full donor myeloid	Full donor T	Full donor B	Acute GVHD	Response and status (d after transplantation)
01	CLL	A→O	Sib	151^1-213	NT	NT	NT	No	CR	A (518)
02	MM	A→O	MUD	44	26^*	26^*	26^*	No	Prog	D (427)
03	LGNHL	A→O	Sib	64	88^*	459	88^*	No	CR	A (725)
04	MM	A→O	MUD	67	88^*	238	88^*	No	PR	A (725)
05	HGNHL	A→O	MUD	49^1-213	45^*	286^1-213	45^*	No	CR	A (416)
06	MM	B→O	Sib	39	32^*	335	32^*	No	Prog	A (438)
07	HD	B→O	Sib	71	43^*	43^*	43^*	No	CR	A (1496)
08	MM	B→O	MUD	53	87^*	87^*	87^*	Gd 2	PR	A (731)
09	CML	A→B	Sib	88	195^*	728	195^*	No	CR	A (910)
10	MM	A→B	MUD	60	25^*	469^1-213	25^*	Gd 2	Prog	A (567)
11	HD	B→A	Sib	92	32^*	32^*	32^*	No	CRu	A (532)
12	HD	B→A	MUD	91^1-213	32^*	32^*	32^*	No	CRu	A (98)
13	LGNHL	AB→A	MUD	39	45^*	45^*	45^*	Gd 2	CR	A (433)
14	MM	AB→A	Sib	133	NT	NT	NT	No	PR	A (525)
15	LGNHL	AB→A	MUD	207^1-213	NT	NT	NT	No	PR	A (238)

CLL indicates chronic lymphocytic leukemia; MM, multiple myeloma; LG/HGNHL, low grade/high grade non-Hodgkin lymphoma; HD, Hodgkin disease; CML, chronic myeloid leukemia; Do, donor; R, recipient; Sib, sibling; MUD, matched unrelated donor; NT, not tested (lack of pretransplant donor material or lack of informative primers); Gd, grade; CR, complete response; Prog, disease progression; PR, partial response; CRu, CR uncertain; A, alive; and D, dead.

F1-213

Censored data point.

First time point tested.

†

Isohemagglutinin titers available in 6 cases (median, 128; range, 16-512).

View Large

This Feature Is Available To Subscribers Only